Dh. Barouch et al., Vaccine-elicited immune responses prevent clinical AIDS in SHIV89.6P-infected rhesus monkeys, IMMUNOL LET, 79(1-2), 2001, pp. 57-61
Accumulating evidence has demonstrated the importance of cytotoxic T lympho
cytes (CTLs) and helper T lymphocytes in controlling HIV-1 replication. We
have elicited immune responses in rhesus monkeys utilizing DNA vaccines aug
mented by the administration of IL-2/Ig, a fusion protein consisting of int
erleukin-2 and the Fc portion of IgG2. These vaccine-elicited immune respon
ses did not prevent infection following a high-dose intravenous challenge w
ith SHIV89.6P but did control viremia to nearly undetectable levels and pre
vented immunodeficiency and clinical disease. In contrast, control monkeys
developed high levels of viremia, and exhibited a rapid loss of CD4(+) T ce
lls, significant clinical disease progression, and death in half of the ani
mals by day 140 following challenge. Vaccine approaches that elicit immune
responses capable of reducing plasma viral loads, but not capable of induci
ng sterilizing immunity, may still provide substantial clinical benefits. (
C) 2001 Elsevier Science B.V. All rights reserved.